Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Potvin D, DiLiberti CE, Hauck WW, Parr AF, Schuirmann DJ, Smith RA. Sequential design approaches for bioequivalence studies with crossover designs. Pharm Stat. 2008;7(4):245–62.
2. Montague TH, Potvin D, Diliberti CE, Hauck WW, Parr AF, Schuirmann DJ. Additional results for ‘Sequential design approaches for bioequivalence studies with crossover designs’. Pharm Stat. 2012;11(1):8–13.
3. Karalis V, Macheras P. An insight into the properties of a two-stage design in bioequivalence studies. Pharm Res. 2013;30(7):1824–35.
4. Maurer W, Jones B, Chen Y. Controlling the type I error rate in two-stage sequential adaptive designs when testing for average bioequivalence. Stat Med. 37(10):1587–607.
5. Kieser M, Rauch G. Two-stage designs for cross-over bioequivalence trials. Stat Med. 2015;34(16):2403–16.